Raymond Booth

Raymond Booth is a Professor in the Department of Pharmaceutical Sciences at Northeastern University and serves as Associate Director for the Center for Drug Discovery. His research focuses on serotonin receptor-targeting therapeutics for CNS disorders, including autism, epilepsy, anxiety, and substance use disorders, supported by NIH grants and industry collaborations like Seropeutics.

• PhD in Pharmaceutical Sciences, University of California at San Francisco
• BS in Pharmacy, Northeastern University

Booth's work integrates computational chemistry, molecular neuropharmacology, and preclinical behavioral models to develop novel chemical entities. His laboratory advances candidates toward Investigational New Drug Applications, emphasizing 5-HT2 receptor modulation.

Recent publications highlight 2-aminotetralin derivatives targeting serotonin and adrenergic receptors, with translational studies in rodents and primates. Awards include appointments to autism and substance use research panels by federal agencies.

• 2023 – Programmatic Panel for Autism Research, Congressionally Directed Medical Research Programs
• 2021 – Board of Scientific Counselors, National Institute on Drug Abuse
• 2017 – Chair of the Panel on New Molecular Entities to Treat Substance Use Disorder, NIDA

He leads grants from National Institute on Drug Abuse (T32, R01) and holds multiple patents for serotonin receptor modulators. His mentorship extends to pharmaceutical sciences graduate students and collaborators in neurodevelopmental disorder research.